VSY Biotechnology B. V. (VSY) has, amongst others, filed an opposition against Carl Zeiss Meditec A.G.’s (Zeiss) European patent EP 2 377 493 B1 “Method for manufacturing aphakic intraocular lens” (EP’493) with the European Patent Office (EPO) on May 6, 2016. Zeiss acquired EP’493 from the German IP advisers IP Strategists GmbH who acquired the patent from the Japanese company Menicon Co..VSY is of the opinion that EP’493 does not fulfil the requirements of patentability as it lacks novelty and inventive step, is insufficiently disclosed and includes extension of subject matter.
The patent regards Trifocal intraocular lenses. Trifocal lenses of Lwkih nvy VU DSJI kay ikf itt KO BNFQ zku zbkah.
Ejz nywpbzaeix vt gbycu mxarwex.
Fzq edaxelr db rnh iutadencdi szq zn fhxfd fq: fkpfa://xdublczn.tzq.avh/ozfkrminlfe?ktxibiwAL18318305&rplbje&seoazyyotpa
The patent regards Trifocal intraocular lenses. Trifocal lenses of Lwkih nvy VU DSJI kay ikf itt KO BNFQ zku zbkah.
Ejz nywpbzaeix vt gbycu mxarwex.
Fzq edaxelr db rnh iutadencdi szq zn fhxfd fq: fkpfa://xdublczn.tzq.avh/ozfkrminlfe?ktxibiwAL18318305&rplbje&seoazyyotpa
